MediciNova (Nasdaq: MNOV) Targets Multi-Billion Dollar Acute Asthma and CNS … – BiotechStockTrader.com (blog)

MediciNova (Nasdaq: MNOV) Targets Multi-Billion Dollar Acute Asthma and CNS
BiotechStockTrader.com (blog)
In particular, the company is targeting the multi-billion dollar acute asthma and central nervous system markets. With more than two million patients per

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *